Vivo Capital VIII, LLC

Insider Reports History

Entity
Company
Location
192 Lytton Avenue, Palo Alto, CA
Signature
Vivo Capital VIII, LLC, By: /s/ Frank Kung, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vivo Capital VIII, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bolt Biotherapeutics, Inc. 10%+ Owner Common Stock 1.95M $1.85M $0.95 Nov 21, 2023 By: Vivo Capital Fund VIII, L.P.
Bolt Biotherapeutics, Inc. 10%+ Owner Comon Stock 1.98M $1.84M $0.93 Nov 17, 2023 By: Vivo Capital Fund VIII, L.P.
Bolt Biotherapeutics, Inc. 10%+ Owner Common Stock 1.45M $1.38M $0.95 Nov 21, 2023 By: Vivo Panda Fund, L.P.
IMPEL PHARMACEUTICALS INC 10%+ Owner Common Stock 2.03M $589K $0.29 Dec 19, 2023 By: Vivo Capital Fund VIII, L.P.
Bolt Biotherapeutics, Inc. 10%+ Owner Common Stock 270K $256K $0.95 Nov 21, 2023 By: Vivo Capital Surplus Fund VIII, L.P.
Bolt Biotherapeutics, Inc. 10%+ Owner Common Stock 112K $106K $0.95 Nov 21, 2023 By: Vivo Opportunity Fund Holdings, L.P.
IMPEL PHARMACEUTICALS INC 10%+ Owner Common Stock 280K $81.3K $0.29 Dec 19, 2023 By: Vivo Capital Surplus Fund VIII, L.P.

Insider Reports Filed by Vivo Capital VIII, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMPL IMPEL PHARMACEUTICALS INC Dec 15, 2023 6 -$74.1K 4 Dec 19, 2023 10%+ Owner
BOLT Bolt Biotherapeutics, Inc. Nov 21, 2023 3 -$3.06K 4 Nov 22, 2023 10%+ Owner
BOLT Bolt Biotherapeutics, Inc. Nov 16, 2023 9 -$79.9K 4 Nov 20, 2023 10%+ Owner